Mirae Asset Global Etfs Holdings Ltd. Krystal Biotech, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 15,893 shares of KRYS stock, worth $2.16 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,893
Previous 15,205
4.52%
Holding current value
$2.16 Million
Previous $2.38 Million
20.28%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding KRYS
# of Institutions
328Shares Held
24.3MCall Options Held
299KPut Options Held
97.6K-
Black Rock Inc. New York, NY3.95MShares$537 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$384 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$372 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$167 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$130 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.49B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...